RELB and neoplasm: To evaluate whether knocking down RelA, RelB, and c‐Rel results in similar suppressive effects in vivo, we injected nude mice with RelA, RelB, c‐Rel, or control shRNA‐transduced U2OS cells and monitored the tumorigenesis for 30 days by measuring tumor volumes at 5‐day intervals.